Boston Scientific Launched Next-Generation Insertable Cardiac Monitor
On October 2, 2023, Boston Scientific, announced the launch of its next-generation LUX-Dx II+ insertable cardiac monitor (ICM) system.
Long-term monitoring is provided by the system for arrhythmias connected to conditions like AFib, cryptogenic stroke, and syncope. Before notifying clinicians, Boston Scientific designed the LUX-Dx II+ with dual-stage algorithms to find and confirm potential arrhythmias. When the clinicians eventually receive an alert, it gives them useful information for clinical decision-making.
Additionally, LUX-Dx II+ has remote programming capabilities. Without an...